Abstract 6571: The “As Low As Reasonably Achievable” Policy: Have We Moved the Needle?
Circulation · 02.11.2026 · 154 (Suppl_1)
DOI: 10.1161/circ.154.suppl_1.6571 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Lichi Zhang und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Health concerns regarding low-dose ionizing radiation (LDIR) have been rising over recent decades. They are of particular importance in congenital heart disease (CHD) populations where survival comes at the cost of repeated imaging modalities using LDIR. The “As Low As Reasonably Achievable” (ALARA) policy was introduced in 2004 aiming to reduce exposure to radiation in medical practice. With this study, we aim to assess the time trend of cardiac LDIR procedures in CHD populations and evaluate if the implementation of the ALARA policy has reduced the use of cardiac LDIR procedures.
Methods
We conducted a population-based time-trend study using the Québec CHD database, which contains demographic data, vital information, medical claims and hospitalization records for 137,894 CHD patients in Québec (1983-2017). Cardiac LDIR procedures were categorized into 4 types using validated procedural codes: cardiac computed tomograph (CT), diagnostic catheterization, interventional catheterization, and pacemaker implantations. We described the temporal trend of these procedures using yearly rate (per 1000 patients), annual percent change (APC), and average annual percent change (AAPC) in 8 subgroups stratified by age (0-4, 5-17, 18-39, 40-64 years) and CHD lesion severity (severe vs. non-severe). We used Joinpoint regression models to detect change points.
Results
Overall, CHD patients with severe lesions showed higher rates of cardiac LDIR procedures than those with non-severe lesions in all age groups other than 40-64. The yearly rate of cardiac CT increased substantially for all 8 subgroups, with the highest AAPC of 10.5% observed in non-severe patients aged 40-64. Temporal trends for other procedures varied by CHD severity and age. Among severe patients, temporal trends were mostly stable or increasing. Among non-severe patients, procedure rates were relatively stable at low level in younger groups but were increasing rapidly with fluctuations in the group aged 40-64, eventually surpassing the rates observed in severe CHD patients. Joinpoint analysis identified significant change points at year 2010 and 2011 in this particular group. The APCs before vs. after the change point were 13.4% vs. 4.0% (p < 0.0001), 9.6% vs. -4.5% (p < 0.05), 16.7% vs. -9.0% (p < 0.0001), and 12.4% vs. -6.0% (p < 0.0001) for cardiac CT, diagnostic catheterization, interventional catheterization, and pacemaker implantation, respectively.
Conclusion
Cardiac LDIR use increased over time in the CHD population, especially among patients with severe lesions and in the use of CT. There was no evidence of significant reduction in the use of cardiac LDIR procedures in CHD patients following the implementation of the ALARA policy. The distinct temporal trend observed in patients aged 40-64 with non-severe CHD lesions suggests factors other than the ALARA drove the change, warranting further exploration.
Zitieren
APA
Zhang, L., Liu, A., Guo, L., Therrien, J., Kaufman, J. S., & Marelli, A. J. (2026). Abstract 6571: The “As Low As Reasonably Achievable” Policy: Have We Moved the Needle?. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.6571
Vancouver
Zhang L, Liu A, Guo L, Therrien J, Kaufman JS, Marelli AJ. Abstract 6571: The “As Low As Reasonably Achievable” Policy: Have We Moved the Needle?. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.6571
BibTeX
@article{Zhang2026,
author = {Zhang, Lichi and Liu, Aihua and Guo, Liming and Therrien, Judith and Kaufman, Jay S and Marelli, Ariane J},
title = {Abstract 6571: The “As Low As Reasonably Achievable” Policy: Have We Moved the Needle?},
journal = {Circulation},
year = {2026},
volume = {154},
number = {Suppl_1},
doi = {10.1161/circ.154.suppl_1.6571}
}
EUVIMED